Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.
Tisoncik-Go J, Voss KM, Lewis TB, Muruato AE, Kuller L, Finn EE, Betancourt D, Wangari S, Ahrens J, Iwayama N, Grant RF, Murnane RD, Edlefsen PT, Fuller DH, Barber GN, Gale M Jr, O'Connor MA. Tisoncik-Go J, et al. Among authors: muruato ae. Front Virol. 2023;3:1108420. doi: 10.3389/fviro.2023.1108420. Epub 2023 Feb 28. Front Virol. 2023. PMID: 37383986 Free PMC article.
Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY. Liu Y, et al. Among authors: muruato ae. Nat Commun. 2022 Oct 13;13(1):6060. doi: 10.1038/s41467-022-33878-6. Nat Commun. 2022. PMID: 36229471 Free PMC article. No abstract available.
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.
Ku Z, Xie X, Lin J, Gao P, Wu B, El Sahili A, Su H, Liu Y, Ye X, Tan EY, Li X, Fan X, Goh BC, Xiong W, Boyd H, Muruato AE, Deng H, Xia H, Zou J, Kalveram BK, Menachery VD, Zhang N, Lescar J, Shi PY, An Z. Ku Z, et al. Among authors: muruato ae. Nat Commun. 2022 Sep 22;13(1):5552. doi: 10.1038/s41467-022-33284-y. Nat Commun. 2022. PMID: 36138032 Free PMC article.
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY. Liu Y, et al. Among authors: muruato ae. Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z. Nat Commun. 2022. PMID: 35896528 Free PMC article.
ZIKV can infect human term placentas in the absence of maternal factors.
Villazana-Kretzer DL, Wuertz KM, Newhouse D, Damicis JR, Dornisch EM, Voss KM, Muruato AE, Paymaster JA, Schmiedecke SS, Edwards SM, Napolitano PG, Tisoncik-Go J, Ieronimakis N, Gale M Jr. Villazana-Kretzer DL, et al. Among authors: muruato ae. Commun Biol. 2022 Mar 18;5(1):243. doi: 10.1038/s42003-022-03158-6. Commun Biol. 2022. PMID: 35304593 Free PMC article.
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Plante JA, Bopp NE, Kurhade C, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY. Liu Y, et al. Among authors: muruato ae. bioRxiv [Preprint]. 2022 Feb 15:2022.02.14.480460. doi: 10.1101/2022.02.14.480460. bioRxiv. 2022. PMID: 35194609 Free PMC article. Updated. Preprint.
Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth.
Ku Z, Xie X, Lin J, Gao P, El Sahili A, Su H, Liu Y, Ye X, Li X, Fan X, Goh BC, Xiong W, Boyd H, Muruato AE, Deng H, Xia H, Jing Z, Kalveram BK, Menachery VD, Zhang N, Lescar J, Shi PY, An Z. Ku Z, et al. Among authors: muruato ae. bioRxiv [Preprint]. 2022 Feb 1:2022.02.01.478504. doi: 10.1101/2022.02.01.478504. bioRxiv. 2022. PMID: 35132410 Free PMC article. Updated. Preprint.
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
Ku Z, Xie X, Davidson E, Ye X, Su H, Menachery VD, Li Y, Yuan Z, Zhang X, Muruato AE, I Escuer AG, Tyrell B, Doolan K, Doranz BJ, Wrapp D, Bates PF, McLellan JS, Weiss SR, Zhang N, Shi PY, An Z. Ku Z, et al. Among authors: muruato ae. Nat Commun. 2021 Jul 1;12(1):4177. doi: 10.1038/s41467-021-24440-x. Nat Commun. 2021. PMID: 34210985 Free PMC article. No abstract available.
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. Xie X, et al. Among authors: muruato ae. Nat Commun. 2021 Jun 21;12(1):3984. doi: 10.1038/s41467-021-24300-8. Nat Commun. 2021. PMID: 34155200 Free PMC article. No abstract available.
39 results